Biotech & rare disease recruiting advisory building patient-centric teams since 1990s.
Two new tablets, a look at "smouldering" MS, and what the research says about staying on treatment when you're stable.
Oct 30, 2026
•
5 min read
The Connector's Corner
Oct 16, 2026
6 min read
The Connector's Corner — Friday, October 9, 2026
Oct 8, 2026
4 min read
Aug 21, 2026
Rare disease momentum, MS data, and the leaders building what comes next
Aug 14, 2026
3 min read
Aug 7, 2026
Jul 24, 2026
Jul 17, 2026
2 min read
Jul 9, 2026